{"entity":{"type":"insider","cik":"0001807910","url":"/insider/0001807910","json_url":"/insider/0001807910.json","name":"Voliotis Dimitris","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":2,"first":"2022-01-20","last":"2022-02-14","span_basis":"filed_date"},"name_variants":[{"name":"Voliotis Dimitris","source":"filing","n_filings":2,"first_seen":"2022-01-20","last_seen":"2022-02-14"}],"transactions":[{"id":6104938,"accession":"0001725160-22-000035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001725160-22-000035","line_url":"/filing/0001725160-22-000035","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807910","owner_name":"Voliotis Dimitris","owner_display_name":"Voliotis Dimitris","owner_url":"/insider/0001807910","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":601.0,"shares_display":"601","price_per_share":50.22919334442596,"price_display":"50.23","price_state":"stated","total_value":30187.7452,"total_display":"30,187.75","total_whole":"30,188","shares_owned_after":16045.0,"shares_owned_after_display":"16,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-14","filed_date":"2022-02-14","scope":"insider","n_lines":2},{"id":6500295,"accession":"0001725160-22-000015","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001725160-22-000015","line_url":"/filing/0001725160-22-000015","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807910","owner_name":"Voliotis Dimitris","owner_display_name":"Voliotis Dimitris","owner_url":"/insider/0001807910","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":60.63233474,"price_display":"60.63","price_state":"stated","total_value":606323.3474,"total_display":"606,323.35","total_whole":"606,323","shares_owned_after":7907.0,"shares_owned_after_display":"7,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-20","filed_date":"2022-01-20","scope":"insider","n_lines":2},{"id":6500289,"accession":"0001725160-22-000015","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001725160-22-000015","line_url":"/filing/0001725160-22-000015","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807910","owner_name":"Voliotis Dimitris","owner_display_name":"Voliotis Dimitris","owner_url":"/insider/0001807910","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":60.79306565,"price_display":"60.79","price_state":"stated","total_value":607930.6565,"total_display":"607,930.66","total_whole":"607,931","shares_owned_after":8361.0,"shares_owned_after_display":"8,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-19","filed_date":"2022-01-20","scope":"insider","n_lines":3},{"id":6500282,"accession":"0001725160-22-000015","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001725160-22-000015","line_url":"/filing/0001725160-22-000015","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807910","owner_name":"Voliotis Dimitris","owner_display_name":"Voliotis Dimitris","owner_url":"/insider/0001807910","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":62.64912233,"price_display":"62.65","price_state":"stated","total_value":626491.2233,"total_display":"626,491.22","total_whole":"626,491","shares_owned_after":12841.0,"shares_owned_after_display":"12,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-20","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001725160","name":"Zentalis Pharmaceuticals, Inc.","url":"/issuer/0001725160","role":"Officer (SVP, Clinical Development)","n_filings":2,"first_seen":"2022-01-20","last_seen":"2022-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001807910","retrieved_at":"2026-08-22T17:52:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}